Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H3 Agents: Synthesis and Biological Evaluation
Molecules · 2024
DOI: 10.3390/molecules29225240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Quxiang Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nanjing Tech University, 30th South Puzhu Road, Nanjing 211816, China. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Serotonin Plasma Membrane Transport Proteins, Receptors, Histamine H3, Antidepressive Agents. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Project (2017ZX0931057), Jiangsu key R&D plan (BE2019738), National Key R&D Program of China (2023YFF0723400) and Jiangsu…, National Science and Technology Major Project, Jiangsu key R&D plan.
Abstract (Originalsprache)
In this research, a variety of novel amphetamine derivatives were synthesized and assessed for their potential as multifaceted antidepressant agents. Among these compounds, compound 11b demonstrated potent inhibitory effects on both serotonin and noradrenaline transporters (SERT/NET) and high affinity for histamine H3 receptor (H3R), and displayed low affinity for off-target receptors (H1, α1) and hERG channels, which can reduce the prolongation of the QT interval. Molecular docking studies offered a rational binding model of compound 11b when it forms a complex with SERT, NET, and the histamine H3 receptor. In vivo behavioral studies, compound 11b dose-dependently reduced the immobility duration in the mouse FST and TST assays without a stimulatory effect on the locomotor activity. Furthermore, compound 11b had a favorable pharmacokinetic profile in rats. Thus, compound 11b has the potential to develop a novel class of drugs for the treatment of depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Nanjing Tech University, 30th South Puzhu Road, Nanjing 211816, China.
- Jiangsu Key Laboratory of Central Nervous System Drug Research and Development, Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, China.
- Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, China.
ORCID-Profile: Quxiang Li, Lili Ren, Dongli Wang, Junyong Luo, Changda Xu, Jian Feng, Yufan Qiu, Xiangqing Xu
Förderung
- National Science and Technology Major Project (2017ZX0931057), Jiangsu key R&D plan (BE2019738), National Key R&D Program of China (2023YFF0723400) and Jiangsu…
- National Science and Technology Major Project
- Jiangsu key R&D plan
- National Key R&D Program of China
- Jiangsu Key Laboratory of Central Nervous System Drug Research and Development
Zitieren
APA
Li, Q., Ren, L., Wang, D., Luo, J., Xu, C., Feng, J., Qiu, Y., Xu, X., & Chen, G. (2024). Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H3 Agents: Synthesis and Biological Evaluation. Molecules. https://doi.org/10.3390/molecules29225240
Vancouver
Li Q, Ren L, Wang D, Luo J, Xu C, Feng J, et al. Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H3 Agents: Synthesis and Biological Evaluation. Molecules. 2024. doi:10.3390/molecules29225240
BibTeX
@article{Li2024,
author = {Li, Quxiang and Ren, Lili and Wang, Dongli and Luo, Junyong and Xu, Changda and Feng, Jian and Qiu, Yufan and Xu, Xiangqing and Chen, Guoguang},
title = {Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H3 Agents: Synthesis and Biological Evaluation},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29225240}
}
EUVIMED